Comparison

Regfo vs Weave Bio

Weave Bio is a well-funded ($36M) platform that spans preclinical through postmarket. Regfo concentrates on the IND preparation window — gap analysis against ICH/FDA with paragraph-level citations. Different buyers, different checks.

Try Regfo free See pricing

Why this comparison comes up

You are evaluating AI for IND work and Weave Bio came up in sales cycles.
Enterprise pricing does not fit a Series A–C team yet.
You want to test compliance depth before committing to a multi-year platform.

At-a-glance

Dimension	Regfo	Weave Bio	Edge
Product scope	IND-focused compliance analysis and gap detection.	End-to-end regulatory platform: preclinical → postmarket.	Depends
Team and funding	Small, focused team. Ships weekly.	$36M raised, enterprise-oriented sales motion.	Them
Pricing visibility	Public: $0 · $399 · $999.	ACV estimated at $100K+ (sales-assisted).	Regfo
Time to first value	Same-day: upload, get citation-level findings.	Multi-week onboarding typical for platforms at that ACV.	Regfo
Coverage	Preclinical compliance (24 ICH, 1,054 rules).	Broader modules across the lifecycle.	Them

Where the two tools actually differ

Scope and commitment

Weave Bio is a platform play — you buy breadth across preclinical, clinical, CMC, and postmarket, and you commit to an implementation. Regfo is a point solution: a team can start with a study report in the morning and be reviewing the first compliance dashboard the same afternoon. If you are about to file an IND, the point solution gets you there first. If you are centralising regulatory across a growing portfolio, the platform story is stronger.

Regfo

Narrow and sharp — the job is the IND window, nothing else fighting for attention.

Weave Bio

Wide and integrated — worth it when the whole lifecycle is in scope.

Analytical depth on preclinical gaps

The specific thing a regulatory lead cares about two weeks before filing is: "what will cause an amendment?" Regfo answers with a structured list — citation, severity, which study report triggered it, and what to do about it. Weave Bio covers the same ground as part of its broader submissions module. The question is whether you need a focused gap analysis this week or an integrated submissions workspace for the next year.

Regfo

Paragraph-level citations, 46 data points extracted per study.

Weave Bio

Integrated with the rest of the submission lifecycle.

Pricing and buyer profile

Weave Bio is priced for a mid-to-large regulatory organisation. Public signals suggest ACVs of $100K+. Regfo is priced for the emerging biotech that has raised a Series A or B and needs to file an IND with a team of one to ten. If your CFO is still counting seats on Notion, $999/mo reads very differently from $100K+/year.

Regfo

Free ($0), Pro ($399/mo), Team ($999/mo). 20% off annual. No setup fees, no implementation contracts.

Weave Bio

Enterprise-oriented — suited to bigger budgets and teams.

Pricing

Weave Bio is quote-driven. Regfo publishes every tier.

Free

1 workspace · 5 uploads · Phase 1

Pro

$399/mo

Unlimited · Phase 1–3 + NDA · all modifiers

Team

$999/mo

10 seats · document generation · audit trail

Note on Weave Bio: Platform tooling typically adds implementation fees, user-tier seat costs, and integration scoping.

Pick Regfo if

Series A–C biotech filing their first or second IND
Teams of 1–10 regulatory/preclinical staff
Any group that wants to validate compliance depth before a long platform commitment

Pick Weave Bio if

Mid-to-large regulatory organisations with budget for integrated platforms
Companies managing preclinical through postmarket across a portfolio

Moving from Weave Bio to Regfo

What transfers

Your study reports drop straight into Regfo — nothing proprietary to export first.

Manual steps

If you already have a submissions taxonomy inside Weave Bio, re-create the workspace structure in Regfo (usually under an hour for one program).

Support

Custom onboarding included on Team. Migration walkthroughs available on request.

Frequently asked

Is Regfo a direct replacement for Weave Bio?

Not at the platform level. Regfo replaces the gap-analysis workflow for IND-stage teams. Companies needing a full lifecycle platform may still choose Weave Bio.

Does Regfo handle postmarket submissions?

No. Regfo covers Phase 1–3 and NDA at the compliance-analysis layer. Postmarket lifecycle is outside scope today.

What is the main reason teams pick Regfo over Weave Bio?

Time and price. Regfo is usable the day you sign up and costs under $1,000/mo — appropriate for Series A–C teams.

Other comparisons

Regfo vs Complizen Regfo vs Qualio Regfo vs MasterControl Regfo vs Veeva Systems

Run your study package through Regfo — free.

1 workspace, 5 uploads, citation-level findings. No credit card.

Start free